LMR 3

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

: continuous link in the transmission of harmful microorganisms between a source and a susceptible host

CHAIN OF INFECTION

: institutional policy to provide customer satisfaction

TOTAL QUALITY MANAGEMENT (TQM)

: institutional program that focuses on customer satisfaction and expectations

CONTINUOUS QUALITY IMPROVEMENT (CQI)

? angle light scatter: light scattered at an angle of less than 90 degrees, which indicates the SIZE OF A CELL

FORWARD

FORWARD angle light scatter: light scattered at an angle of less than 90 degrees, which indicates the ?

SIZE OF A CELL

FORWARD angle light scatter: light scattered at an angle of less than ? degrees, which indicates the SIZE OF A CELL

, right angle light scatter: light scattered at 90 degrees in a flow cytometer that indicates the GRANULARITY OF A CELL

SIDE ANGLE

SIDE ANGLE, right angle light scatter: light scattered at 90 degrees in a flow cytometer that indicates the ?

GRANULARITY OF A CELL

SIDE ANGLE, ? light scatter: light scattered at 90 degrees in a flow cytometer that indicates the GRANULARITY OF A CELL

right angle

: measures TOTAL IgE

RADIOIMMUNOSORBENT TEST (RIST)

RADIOIMMUNOSORBENT TEST (RIST): measures

TOTAL IgE

: measures ANTIGEN-SPECIFIC IgE

RADIOALLERGOSORBENT TEST (RAST)

RADIOALLERGOSORBENT TEST (RAST): measures

ANTIGEN-SPECIFIC IgE

: RNA viral cause of German or 3-day measles

RUBELLA

RUBELLA: RNA viral cause of ? or ? measles

German or 3-day measles

: single-stranded RNA virus that cause measles

RUBEOLA

: amoeboid movement of cells such as monocytes and polymorphonuclear neutrophils to a site of inflammation in phagocytosis

DIAPEDESIS

: congenital defect of the third and fourth pharyngeal pouches that affects thymic development, leading to a T-cell deficiency. Patients are subject to recurring viral and fungal infections

DiGeorge anomaly

: dysproteinemia synonymous with gamma heavy-chain disease. This abnormality is characterized by the presence of monoclonal protein composed of the heavy-chain portion of the immunoglobulin molecule.

Franklin’s disease

An alternate term for multiple myeloma

Kahler’s disease

Kahler’s disease An alternate term for

multiple myeloma

: molecule that when coupled to a hapten, makes the hapten capable of stimulating an immune response

CARRIER

: simple chemical group that can bind to antibody once it is formed but that CANNOT stimulate antibody formation unless tied to a larger carrier molecule

HAPTEN

: single antigenic determinant. It is functionally the portion of an antigen that combines with an antibody paratope

EPITOPE

: part of the antibody molecule that makes contact with the antigenic determinant

PARATOPE

: frequency of positive results obtained in testing a population of individuals who are positive for antibody

SENSITIVITY

: proportion of negative test results obtained in the population of individuals who actually lack the antibody in question

SPECIFICITY

: antigens that are expressed in the developing fetus and in rapidly dividing tissue, such as that associated with tumors, but that are absent in normal adult tissue

ONCOFETAL ANTIGENS

: malignant tumor of EPITHELIAL TISSUE origin

CARCINOMA

CARCINOMA: malignant tumor of ? origin

EPITHELIAL TISSUE

: malignant tumor of CONNECTIVE TISSUE origin

SARCOMA

. : DR. Teodoro “Ted” Herbosa

DOH SECRETARY

. DOH SECRETARY:

DR. Teodoro “Ted” Herbosa

DRIVING FORCE of the bicarbonate buffer system is .

CARBON DIOXIDE

of the bicarbonate buffer system is CARBON DIOXIDE.

DRIVING FORCE

: time from ordering a test through analysis in the laboratory to the charting of the report

TURNAROUND TIME (TAT)

should be labeled with a description of their particular hazard, such as POISONOUS, CORROSIVE OR CARCINOGENIC.

Hazardous chemicals

Hazardous chemicals should be labeled with a description of their particular hazard, such as ? 3

POISONOUS, CORROSIVE OR CARCINOGENIC.

Information contained in the ? includes the following: physical and chemical characteristics, fire and explosion potential, reactivity potential, health hazards and methods for safe handling.

Material Safety Data Sheets (MSDS)

? is placed with a SPINNING MOTION. The scale reading is then taken at the BOTTOM OF THE URINE MENISCUS.

Urinometer

Urinometer is placed with a ? MOTION. The scale reading is then taken at the BOTTOM OF THE URINE MENISCUS.

SPINNING

Urinometer is placed with a SPINNING MOTION. The scale reading is then taken at the BOTTOM OF THE URINE ?.

MENISCUS

Studies have shown that although everyone who eats ? produces a urine odor, ONLY certain genetically predisposed people can smell the odor

ASPARAGUS

urine odor: METHIONINE MALABSORPTION

CABBAGE

CABBAGE urine odor:

METHIONINE MALABSORPTION

The heme portion of ? IS TOXIC TO RENAL TUBULES and high concentrations can cause acute renal failure

MYOGLOBIN

The heme portion of MYOGLOBIN IS TOXIC TO ? and high concentrations can cause acute renal failure

RENAL TUBULES

The heme portion of MYOGLOBIN IS TOXIC TO RENAL TUBULES and high concentrations can cause ?

acute renal failure

have tendency to locate NEAR THE EDGES OF THE COVERSLIP.

CASTS

(anti-freeze) poisoning: MONOHYDRATE CAOX

ETHYLENE GLYCOL

ETHYLENE GLYCOL (anti-freeze) poisoning:

MONOHYDRATE CAOX

: coffin-lid or FEATHERY APPEARANCE (as they disintegrate)

TRIPLE PHOSPHATE

TRIPLE PHOSPHATE: ? APPEARANCE (as they disintegrate)

coffin-lid or FEATHERY

provides a method for counting UNDILUTED seminal fluid. Sperms are immobilized by heating part of the specimen prior to charging the chamber.

MAKLER COUNTING CHAMBER

MAKLER COUNTING CHAMBER provides a method for counting ? seminal fluid. Sperms are immobilized by heating part of the specimen prior to charging the chamber.

UNDILUTED

provides OBJECTIVE determination of both SPERM VELOCITY and TRAJECTORY (DIRECTION OF MOTION).

COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)

COMPUTER-ASSISTED SEMEN ANALYSIS (CASA) provides OBJECTIVE determination of both ? and ? (DIRECTION OF MOTION).

SPERM VELOCITY and TRAJECTORY

A maximum of ? AMNIOTIC FLUID is collected in sterile syringes. The first 2 to 3 mL collected can be contaminated by maternal blood, tissue fluid and cells and are discarded

30 mL

A maximum of 30 mL ? is collected in sterile syringes. The first 2 to 3 mL collected can be contaminated by maternal blood, tissue fluid and cells and are discarded

AMNIOTIC FLUID

? increased RETENTION of water and solutes in the large intestine associated with MALABSORPTION AND MALDIGESTION

OSMOTIC DIARRHEA:

OSMOTIC DIARRHEA: increased ? of water and solutes in the large intestine associated with MALABSORPTION AND MALDIGESTION

RETENTION

OSMOTIC DIARRHEA: increased RETENTION of water and solutes in the large intestine associated with

MALABSORPTION AND MALDIGESTION

increased SECRETION of water and electrolytes into the large intestine caused by BACTERIAL ENTEROTOXINS

SECRETORY DIARRHEA

SECRETORY DIARRHEA increased SECRETION of water and electrolytes into the large intestine caused by

BACTERIAL ENTEROTOXINS

Plasmapheresis donor, total protein at least

6 g/dL

? donor, total protein at least 6 g/dL

Plasmapheresis

? LEAK POTASSIUM into the plasma or additive solution of the blood component during storage. Rapid infusion of a large volume of packed red blood cells may put patient populations such as neonates and patients with cardiac, hepatic, or renal dysfunction at risk of developing hyperkalemia. The transient hyperkalemia related to massive transfusion appear to be related to the patient’s acid base balance, ionized calcium levels, and rate of infusion of the packed red blood cells.

Packed red blood cells

Packed red blood cells ? into the plasma or additive solution of the blood component during storage. Rapid infusion of a large volume of packed red blood cells may put patient populations such as neonates and patients with cardiac, hepatic, or renal dysfunction at risk of developing hyperkalemia. The transient hyperkalemia related to massive transfusion appear to be related to the patient’s acid base balance, ionized calcium levels, and rate of infusion of the packed red blood cells.

LEAK POTASSIUM

Significant Antibody titer in HDN: 4th edition: significant is ?

Significant Antibody titer in HDN: 5th edition: significant is

16 to 32

Significant Antibody titer in HDN: 6th edition: critical titer is

16181

: individual facility COMPARE ITS RESULTS WITH THOSE OF ITS PEERS

BENCHMARKING

: average value

MEAN

: most frequently occurring value

MODE

: middle value within range

MEDIAN

CONSTANT systematic error -

y-intercept

? systematic error - y-intercept

CONSTANT

PROPORTIONAL systematic error -

SLOPE

? systematic error - SLOPE

PROPORTIONAL

Fungi (dermatophyte) produces macroconidia that are large, multicellular, and club-shaped with smooth walls:

EPIDERMOPHYTON FLOCCOSUM

In ?, 96% of tumors with CA 19-9 levels >1,000 U/mL are considered UNRESECTABLE (cannot be removed completely through surgery).

pancreatic adenocarcinoma

Reporting Mixed Lymphocyte Reaction: either ?

Stimulation Index (SI) or percent relative response (%RR)

: either Stimulation Index (SI) or percent relative response (%RR)

Reporting Mixed Lymphocyte Reaction

are nodules found in the hearts of individuals with RHEUMATIC FEVER

ASCHOFF BODIES

ASCHOFF BODIES are nodules found in the hearts of individuals with

RHEUMATIC FEVER

: must NOT GO through drain disposal

MERCURY

: can be recycled by distillation or by drain disposal, can be detoxified by commercial product, or can be disposed of by licensed waste hauler

FORMALDEHYDE WASTES

: represent the second X chromosome in females and may be seen in 2 to 3% of neutrophils in FEMALES. The number of Barr bodies in a cell is one less than the number of X chromosomes present in a cell

BARR (sex chromatin) BODY or DRUMSTICK

: rough endoplasmic reticulum containing RNA and may represent localized failure of the cytoplasm to mature. They are found in infections, poisoning, burns and following chemotherapy

DOHLE BODIES

: granulocytes usually contain several very large, reddish-purple or greenishgray staining granules in the cytoplasm; in the monocytes and lymphocytes they stain bluish purple and may be present singly, or there may be several in one cell. These granules represent ABNORMAL LYSOSOMES.

CHEDIAK-HIGASHI

CHEDIAK-HIGASHI: granulocytes usually contain several very large, reddish-purple or greenishgray staining granules in the cytoplasm; in the monocytes and lymphocytes they stain bluish purple and may be present singly, or there may be several in one cell. These granules represent

ABNORMAL LYSOSOMES.

of the RBCs is maximal at 37C and decreases as the temperature lowers.

Sickling

Sickling of the RBCs is maximal at 37C and decreases as the temperature ?.

lowers

on top of the red cell should not be confused with RBC inclusion body. There is generally a nonstaining halo surrounding the platelet when it is positioned on top of the RBC.

Platelets

: bubbles and fibrin clots, invalid results

ESR

: measure HUMIDITY

HYGROMETERS

HYGROMETERS: measure

HUMIDITY

ALCOHOL FIXATIVE CONCENTRATIONS; ? because less concentrated solutions will produce lysis of cells.

70% to 100%

Ethanol and methanol, including Carnoy’s solution are commonly used fixatives for ?

nucleic acids.

100

? solution are commonly used fixatives for nucleic acids.

Ethanol and methanol, including Carnoy’s

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前